等待開盤 11-19 09:30:00 美东时间
-3.040
-1.91%
PepGen reports positive Phase 2 results for PGN-EDODM1 in DM1, showing record splicing correction and notable functional improvements.
11-11 02:47
转自:新华财经 新华财经北京11月9日电(记者沈寅飞)第18个“双11”如约而至。记者从阿里健康获悉,为解决我国罕见病患者中不少罕见病药品单价高、用量大、需长期...
11-09 14:54
Celldex posts positive Phase 3 data for barzolvolimab to treat chronic spontaneous urticaria. The company plans a 2027 FDA submission.
09-23 00:25
Novartis shares are trading lower after the company announced the pelacarsen ph...
09-05 04:34
2026年中报落幕,全球药企市值前十榜单剧烈更迭。 今年以来,安进的股价持续走高,截至美东时间8月13日收盘,总市值达到2259亿美元(折合人民币约1.5万亿元...
08-17 11:53
Novartis shares rise as strong Q2 demand for key growth drugs offsets generic competition. NVS beats Q2 earnings and reaffirms 2026 targets.
07-21 20:21
Novartis wins traditional FDA approval for Fabhalta, a first-in-class oral treatment slowing kidney decline in adult IgAN.
07-18 00:19
Novartis acquires Myricx Bio for up to $1.5B to boost its oncology pipeline with a novel next-gen ADC cancer platform. Read more.
07-06 23:13
距离第一次吞下“格列卫”,已经过去了8700多天。 这种曾比黄金还要昂贵的药物,在24年前陆勇确诊慢粒白血病的至暗时刻,让他有了生的希望。然而,也正是这样一粒小...
07-05 13:00
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 来源:破茧Bio 一次BD合作,点燃了投资者对于石药创新的期待。...
07-03 17:00